Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -41.81% is 78% above its 5-year average of -186.11%, near the high end of its 5-year range (-1727.08%–-34.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 59.96% above its 12-month average of -104.40%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -41.81%.
RETURN ON INVESTED CAPITAL (ROIC)
-41.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-104.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-283.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-186.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-88.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+59.96%
CURRENT VS 3Y AVG
+85.27%
CURRENT VS 5Y AVG
+77.54%
CURRENT VS 10Y AVG
+52.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 743 covered companies
CURRENT VS SECTOR MEDIAN
-23.94%
vs the sector median at left
Allarity Therapeutics, Inc.
Market Cap
$15.72M
Return on Invested Capital (ROIC)
-41.81%
TTM Avg
-104.40%
3Y Avg
-283.78%
5Y Avg
-186.11%
Market Cap
$15.90M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-183.21%
3Y Avg
-122.71%
5Y Avg
-100.21%
Market Cap
$16.04M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
Market Cap
$15.42M
Return on Invested Capital (ROIC)
-497.29%
TTM Avg
-141.17%
3Y Avg
-111.65%
5Y Avg
-80.50%
Market Cap
$16.40M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$16.75M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$14.84M
Return on Invested Capital (ROIC)
-48.04%
TTM Avg
-66.55%
3Y Avg
-57.55%
5Y Avg
-44.03%
Market Cap
$16.76M
Return on Invested Capital (ROIC)
-125.44%
TTM Avg
-125.44%
3Y Avg
-1118.57%
5Y Avg
-719.84%
Market Cap
$17.01M
Return on Invested Capital (ROIC)
-88.07%
TTM Avg
-68.32%
3Y Avg
-78.67%
5Y Avg
-76.64%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.72M | -41.81% | -104.40% | -283.78% | -186.11% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.90M | N/A | -183.21% | -122.71% | -100.21% |
| BioCardia, Inc. (BCDA)vs › | $16.04M | -273.70% | -707.06% | -535.27% | -358.40% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | -497.29% | -141.17% | -111.65% | -80.50% |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | -279.48% | -96.52% | -105.30% | -89.17% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | -85.72% | -120.02% | -101.35% | -83.66% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.84M | -48.04% | -66.55% | -57.55% | -44.03% |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | -125.44% | -125.44% | -1118.57% | -719.84% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | -88.07% | -68.32% | -78.67% | -76.64% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.57M | -13.15% | -23.00% | -25.06% | -54.51% |
ROIC
-41.8%
ROE
-348.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -41.81% |
| 2026-03-31 | -43.13% |
| 2025-12-31 | -112.26% |
| 2025-09-30 | -126.89% |
| 2025-06-30 | -197.90% |
| 2025-03-31 | -129.98% |
| 2024-12-31 | -206.98% |
| 2024-09-30 | -173.44% |
| 2024-06-30 | -78.34% |
| 2023-06-30 | -1727.08% |
| 2023-03-31 | -521.49% |
| 2022-12-31 | -577.66% |
| 2022-09-30 | -845.72% |
| 2022-06-30 | -367.17% |
| 2022-03-31 | -230.08% |
| 2021-12-31 | -93.03% |
| 2021-09-30 | -42.84% |
| 2021-06-30 | -34.70% |
| 2021-03-31 | -36.07% |
| 2020-12-31 | -29.34% |
| 2020-09-30 | -83.69% |
| 2020-06-30 | -90.23% |
| 2020-03-31 | -108.62% |
| 2019-12-31 | -96.45% |
| 2019-09-30 | -30.04% |
| 2019-06-30 | -22.68% |
| 2019-03-31 | -18.02% |
| 2018-12-31 | -13.97% |
| 2018-09-30 | -6.72% |
| 2018-03-31 | -27.27% |
| 2017-12-31 | -915.31% |
| 2017-09-30 | -47.86% |
| 2017-06-30 | -47.54% |
| 2017-03-31 | -88.99% |
| 2016-12-31 | -90.14% |
| 2016-09-30 | -76.07% |
| 2016-06-30 | -48.81% |
| 2016-03-31 | -46.55% |
| 2015-12-31 | -30.61% |
